IL-1 Receptor Accessory Protein-Ig/IL-1 Receptor Type II-Ig Heterodimer Inhibits IL-1 Response More Strongly than Other IL-1 Blocking Biopharmaceutical Agents-Reference-Cited by-同舟云学术

IL-1 Receptor Accessory Protein-Ig/IL-1 Receptor Type II-Ig Heterodimer Inhibits IL-1 Response More Strongly than Other IL-1 Blocking Biopharmaceutical Agents

Published:2010-12-22 Issue:3 Volume:31 Page:455-464
ISSN:0271-9142
Container-title:Journal of Clinical Immunology
language:en
Short-container-title:J Clin Immunol

Author:

Hanawa Haruo,Ota Yoshimi,Ding Limin,Chang He,Yoshida Kaori,Otaki Keita,Hao Kazuhisa,Kasahara Sou,Kodama Makoto,Nakazawa Mikio,Aizawa Yoshifusa

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s10875-010-9497-z.pdf

Reference27 articles.

1. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood. 1991;77:1627–52.

2. Arend WP, Dayer JM. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum. 1995;38:151–60.

3. Dinarello CA, Donath MY, Mandrup-Poulsen T. Role of IL-1beta in type 2 diabetes. Curr Opin Endocrinol Diab Obes. 2010;17:314–21.

4. Moyer CF, Sajuthi D, Tulli H, Williams JK. Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis. Am J Pathol. 1991;138:951–60.

5. Garces K. Anakinra: interleukin-1 receptor antagonist therapy for rheumatoid arthritis. Issues Emerg Health Technol. 2001;16:1–4.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological injection therapy with leukocyte-poor platelet-rich plasma induces cellular alterations, enhancement of lubricin, and inflammatory downregulation in vivo in human knees: A controlled, prospective human clinical trial based on mass spectrometry imaging analysis;Frontiers in Surgery;2023-04-21

2. IL1R2, CCR2, and CXCR4 May Form Heteroreceptor Complexes with NMDAR and D2R: Relevance for Schizophrenia;Frontiers in Psychiatry;2017-02-15

3. Postoperative Ileus: Pathophysiology, Current Therapeutic Approaches;Gastrointestinal Pharmacology;2016

4. Postoperative Ileus Involves Interleukin-1 Receptor Signaling in Enteric Glia;Gastroenterology;2014-01